Director's Dealing • Aug 31, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9674K
Drax Group PLC
31 August 2023
31 August 2023
Drax Group plc
("Drax" or "the Company")
Symbol: DRX
Notification of Transactions of Directors,
Persons Discharging Managerial Responsibility or Connected Persons
Paul Sheffield, a PDMR, has notified the Company that on 29 and 30 August 2023 he sold 79,840 ordinary shares of 11 16/29 pence each in the Company at an aggregate price of 552.7038 pence per share. Following the transaction, Paul Sheffield's total shareholding in the Company is 16,318 ordinary shares.
The information below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
Details of PDMR / person closely associated with them ("PCA")
Name
Paul Sheffield
Reason for the notification
Position / status
Chief Commercial Officer
Initial notification / amendment
Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Drax Group plc
LEI
549300YPSNTXR4ZHSR98
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument
Identification code
Ordinary shares of 11 16/29 pence
GB00B1VNSX38
Nature of the transaction
Sale of ordinary shares
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 553.000 pence per share (29 August 2023) 550.808 pence per share (30 August 2023) 551.200 pence per share (30 August 2023) |
67,237 2,460 10,143 |
Aggregated information
- Aggregated volume
- Price
79,840
552.7038 pence per share
Date of the transaction
29 and 30 August 2023
Place of the transaction
XLON
--ENDS--
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPBMLTMTIJMRJ
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.